Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid

Catherine Vilchèze, Feng Wang, Masayoshi Arai, Manzour Hernando Hazbón, Roberto Colangeli, Laurent Kremer, Torin R. Weisbrod, David Alland, James C. Sacchettini, William R. Jacobs

Research output: Contribution to journalArticle

201 Citations (Scopus)

Abstract

Isoniazid is one of the most effective antituberculosis drugs, yet its precise mechanism of action is still controversial. Using specialized linkage transduction, a single point mutation allele (S94A) within the putative target gene inhA was transferred in Mycobacterium tuberculosis. The inhA(S94A) allele was sufficient to confer clinically relevant levels of resistance to isoniazid killing and inhibition of mycolic acid biosynthesis. This resistance correlated with the decreased binding of the INH-NAD inhibitor to InhA, as shown by enzymatic and X-ray crystallographic analyses, and establishes InhA as the primary target of isoniazid action in M. tuberculosis.

Original languageEnglish (US)
Pages (from-to)1027-1029
Number of pages3
JournalNature Medicine
Volume12
Issue number9
DOIs
StatePublished - Sep 2006

Fingerprint

Isoniazid
Mycobacterium tuberculosis
Point Mutation
Alleles
Mycolic Acids
Biosynthesis
Genes
X-Rays
X rays
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. / Vilchèze, Catherine; Wang, Feng; Arai, Masayoshi; Hazbón, Manzour Hernando; Colangeli, Roberto; Kremer, Laurent; Weisbrod, Torin R.; Alland, David; Sacchettini, James C.; Jacobs, William R.

In: Nature Medicine, Vol. 12, No. 9, 09.2006, p. 1027-1029.

Research output: Contribution to journalArticle

Vilchèze, C, Wang, F, Arai, M, Hazbón, MH, Colangeli, R, Kremer, L, Weisbrod, TR, Alland, D, Sacchettini, JC & Jacobs, WR 2006, 'Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid', Nature Medicine, vol. 12, no. 9, pp. 1027-1029. https://doi.org/10.1038/nm1466
Vilchèze, Catherine ; Wang, Feng ; Arai, Masayoshi ; Hazbón, Manzour Hernando ; Colangeli, Roberto ; Kremer, Laurent ; Weisbrod, Torin R. ; Alland, David ; Sacchettini, James C. ; Jacobs, William R. / Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. In: Nature Medicine. 2006 ; Vol. 12, No. 9. pp. 1027-1029.
@article{750edaf5f125442788bd45021a58e9d4,
title = "Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid",
abstract = "Isoniazid is one of the most effective antituberculosis drugs, yet its precise mechanism of action is still controversial. Using specialized linkage transduction, a single point mutation allele (S94A) within the putative target gene inhA was transferred in Mycobacterium tuberculosis. The inhA(S94A) allele was sufficient to confer clinically relevant levels of resistance to isoniazid killing and inhibition of mycolic acid biosynthesis. This resistance correlated with the decreased binding of the INH-NAD inhibitor to InhA, as shown by enzymatic and X-ray crystallographic analyses, and establishes InhA as the primary target of isoniazid action in M. tuberculosis.",
author = "Catherine Vilch{\`e}ze and Feng Wang and Masayoshi Arai and Hazb{\'o}n, {Manzour Hernando} and Roberto Colangeli and Laurent Kremer and Weisbrod, {Torin R.} and David Alland and Sacchettini, {James C.} and Jacobs, {William R.}",
year = "2006",
month = "9",
doi = "10.1038/nm1466",
language = "English (US)",
volume = "12",
pages = "1027--1029",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid

AU - Vilchèze, Catherine

AU - Wang, Feng

AU - Arai, Masayoshi

AU - Hazbón, Manzour Hernando

AU - Colangeli, Roberto

AU - Kremer, Laurent

AU - Weisbrod, Torin R.

AU - Alland, David

AU - Sacchettini, James C.

AU - Jacobs, William R.

PY - 2006/9

Y1 - 2006/9

N2 - Isoniazid is one of the most effective antituberculosis drugs, yet its precise mechanism of action is still controversial. Using specialized linkage transduction, a single point mutation allele (S94A) within the putative target gene inhA was transferred in Mycobacterium tuberculosis. The inhA(S94A) allele was sufficient to confer clinically relevant levels of resistance to isoniazid killing and inhibition of mycolic acid biosynthesis. This resistance correlated with the decreased binding of the INH-NAD inhibitor to InhA, as shown by enzymatic and X-ray crystallographic analyses, and establishes InhA as the primary target of isoniazid action in M. tuberculosis.

AB - Isoniazid is one of the most effective antituberculosis drugs, yet its precise mechanism of action is still controversial. Using specialized linkage transduction, a single point mutation allele (S94A) within the putative target gene inhA was transferred in Mycobacterium tuberculosis. The inhA(S94A) allele was sufficient to confer clinically relevant levels of resistance to isoniazid killing and inhibition of mycolic acid biosynthesis. This resistance correlated with the decreased binding of the INH-NAD inhibitor to InhA, as shown by enzymatic and X-ray crystallographic analyses, and establishes InhA as the primary target of isoniazid action in M. tuberculosis.

UR - http://www.scopus.com/inward/record.url?scp=33748469322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748469322&partnerID=8YFLogxK

U2 - 10.1038/nm1466

DO - 10.1038/nm1466

M3 - Article

C2 - 16906155

AN - SCOPUS:33748469322

VL - 12

SP - 1027

EP - 1029

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 9

ER -